FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 2053387 · Received April 13, 2011

Report

Report Number
2124215-2011-04424
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
March 3, 2011
Report Date
March 3, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS A RESULT, THE LEAD WAS SURGICALLY ABANDONED AND A NEW LEAD WAS SUCCESSFULLY IMPLANTED. THE H170 WAS RETURNED TO THE PATIENT AND THE N119 REMAINS IMPLANTED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D/H170) DETECTED SHOCK IMPEDANCES GREATER THAN 90 OHMS WHILE IMPLANTED WITH THIS CHRONIC RIGHT VENTRICULAR LEAD. THIS DEVICE WAS EXPLANTED FOR NORMAL BATTERY DEPLETION. HOWEVER, DURING THE IMPLANT PROCEDURE GREATER THAN 125 OHMS WAS DETECTED ON THE CHRONIC DEFIBRILLATION LEAD AND NEW CRT-D (N119). NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0184

Patients

Seq Age Sex Outcome Treatment
1 79 YR Required Intervention 4542| H170| MISMATCH| 0184| N119